NFKB1 and cholangiocarcinoma: For cholangiocarcinoma, G1-phase cell cycle arrest was demonstrated with berberine, an alkaloid from Berberis vulgaris and Berberis aquifolium via NF-κB and STAT3 pathways (Puthdee et al., 2017).